Milne Jill C. 4
4 · Astria Therapeutics, Inc. · Filed Mar 3, 2022
Insider Transaction Report
Form 4
Milne Jill C.
DirectorCEO and President
Transactions
- Award
Stock Option (right to buy)
2022-03-01+195,000→ 195,000 totalExercise: $6.51→ Common Stock (195,000 underlying)
Footnotes (1)
- [F1]This option was granted on March 1, 2022, and is subject to vesting over a four year period, with 25% of the shares vesting on the first anniversary of February 17, 2022 and the remainder vesting over the ensuing three years at a rate of 2.0833% per month.